• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Invivyd, Inc. - Common Stock (NQ:IVVD)

    1.165 -0.305 (-20.75%)
    Streaming Delayed Price Updated: 2:15 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8,284,597
    Open 1.320
    Bid (Size) 1.160 (19,100)
    Ask (Size) 1.170 (14,900)
    Prev. Close 1.470
    Today's Range 1.125 - 1.320
    52wk Range 0.4830 - 3.070
    Shares Outstanding 109,755,624
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Invivyd Q1 Earnings Call Highlights ↗
    Invivyd (NASDAQ:IVVD) said its first quarter of 2026 was marked by continued progress in its pivotal COVID-19 antibody program, year-over-year growth for PEMGARDA and elevated clinical spending tied to... 
    Via MarketBeat
    Topics Earnings
    Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge ↗
    Via Chartmill

    Performance

    YTD
    -53.4%
    -53.4%
    1 Month
    -32.3%
    -32.3%
    3 Month
    -27.6%
    -27.6%
    6 Month
    -34.2%
    -34.2%
    1 Year
    +35.3%
    +35.3%

    More News

    Read More
    News headline image
    Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
    From Invivyd
    Via GlobeNewswire
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    News headline image
    Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Presentation at the World Vaccine Congress Washington
    From Invivyd
    Via GlobeNewswire
    News headline image
    BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Invivyd (IVVD) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
    From Invivyd
    Via GlobeNewswire

    Frequently Asked Questions

    Is Invivyd, Inc. - Common Stock publicly traded?
    Yes, Invivyd, Inc. - Common Stock is publicly traded.
    What exchange does Invivyd, Inc. - Common Stock trade on?
    Invivyd, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Invivyd, Inc. - Common Stock?
    The ticker symbol for Invivyd, Inc. - Common Stock is IVVD on the Nasdaq Stock Market
    What is the current price of Invivyd, Inc. - Common Stock?
    The current price of Invivyd, Inc. - Common Stock is 1.165
    When was Invivyd, Inc. - Common Stock last traded?
    The last trade of Invivyd, Inc. - Common Stock was at 05/14/26 02:15 PM ET
    What is the market capitalization of Invivyd, Inc. - Common Stock?
    The market capitalization of Invivyd, Inc. - Common Stock is 127.87M
    How many shares of Invivyd, Inc. - Common Stock are outstanding?
    Invivyd, Inc. - Common Stock has 128M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.